Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy.

Abstract

The ketogenic diet (KD) is an established, effective, nonpharmacologic treatment for children with pharmacoresistant epilepsy. Although the KD is the most well-established dietary therapy for epilepsy, it is too restrictive and is associated with serious complications; therefore, alternative lower-fat diets, including a modified Atkins diet and low-glycemic index diet, have been developed. Recent ongoing clinical evidence suggests that other dietary therapies have an efficacy almost comparable to that of the KD. In addition, a diet rich in polyunsaturated fatty acids appears to increase the efficacy of diet therapy and reduce the complications of a high-fat diet. Here, we review the systematic information about lower-fat diets and better-quality dietary therapies and the current clinical status of each of these dietary approaches.

• Authors: Jung-Rim Yoon, Heung Dong Kim, Hoon-Chul Kang
• Journal: Korean journal of pediatrics (Korean J Pediatr) Vol. 56 Issue 8 Pg. 327-31 (Aug 2013) ISSN: 1738-1061 [Print] Korea (South)
• PMID: 24019842 (Publication Type: Journal Article, Review)